Captured Carbon Dioxide Transforms the Lives of Diabetics

A revolutionary carbon dioxide treatment which could transform the lives of people with diabetes is also playing its part in tackling the climate crisis.

D’OXYVA has proven to be effective in improving blood circulation, which heals diabetic foot ulcers and other serious wounds more quickly, reduces the need for amputations, and eases chronic pain.

A small vapor spray brings carbon dioxide from the surface of the skin into the blood vessels, without pain.

However, any mention of CO2 naturally raises alarm bells about the climate, with the health sector contributing to nearly 5% of global greenhouse gas emissions.

The technology — and the carbon dioxide — used in D’OXYVA, actually helps the environment, as the CO2 is captured at source, so it never reaches the air.

Circularity Healthcare, which developed the new wonder treatment, has partnered with companies capturing carbon dioxide from atmospheric, industrial and vehicle emissions.

The circular carbon economy model is built on the four Rs — reducing, reusing, recycling and removing.

Carbon dioxide is used widely in medicine, for a number of vital purposes, and sourcing it responsibly, by removing it from the atmosphere, has become key to healthcare around the world.

Circularity Healthcare was established to radically change the standard of care and improve lives, while demonstrating the concept of the circular carbon economy.

Based in Pasadena, California, the company makes its products largely out of recycled materials.

Ready To Tackle An Epidemic

The pioneering D’OXYVA uses a unique skin microcirculation technology, dispensing a non-toxic vapor through a mini cartridge filled with ultra-purified CO2 molecules.

The non-invasive treatment has delivered consistent results in 4–8 weeks, based on evidence collected by world-leading medical scientists and doctors at 18 of the top 20 ranked U.S. universities.

In America, the Food and Drug Administration (FDA) declared diabetic foot ulcers as an epidemic.

Amputation might be necessary for as high as 43% of patients diagnosed with a diabetic foot ulcer — until D’OXYVA was proven to be safe and successful.

D’OXYVA should soon become a common treatment for symptoms associated with diabetes. It is in the final stage of receiving an update to its existing FDA approval.

More Information: https://doxyva.com/diabetes/how-does-doxyva-help-diabetics/